Meet
Jenna Ivan

Associate Principal

Jenna Ivan supports clients with research and analysis that span a variety of healthcare sectors and stakeholders.

She applies her background in medical policy, international health, and analytics to a broad range of client projects.

Prior to joining Avalere, Jenna was a research analyst with Third Bridge, where she designed and conducted primary research on the medical, pharmaceutical, and healthcare industries for financial clients. Additionally, Jenna worked as a medical scribe for Scribe America, where she partnered with healthcare providers to maintain electronic medical records.

Jenna attended the University of Notre Dame, where she received an MS in global health and a BA in pre-health and sociology with minors in genetics and economics.

Authored Content

May 21, 2024 | Insights & Analysis > Women's Health

Technology Is Driving Innovation in Women’s Health
The FemTech industry is rapidly growing and evolving as health equity and women’s health research become a larger focus and target priority in the US.
December 20, 2022 | Insights & Analysis > Women's Health

After Roe, Growing Fertility Industry Faces Risks at State Level
Despite market growth, fertility services may be affected by the overturning of Roe v. Wade. The extent and nature of impact will vary by state.
December 16, 2021 | Insights & Analysis > RWE and Patient-Centered Outcomes

Treating Depression Reduces Medicare Costs; Provider Challenges Remain
A recent Avalere analysis of Medicare Fee-for-Service (FFS) data illustrates that treating major depressive disorder (MDD) in Medicare-eligible beneficiaries results in a 4% reduction in total cost compared to untreated patients, highlighting the importance of incentivizing adequate provider supply and payment in the geriatric psychiatry market.
April 19, 2020 | Insights & Analysis > Digital Health

Provider Impact of COVID-19 Telehealth Policies by Specialty
Approximately ⅓ of physician services payments are eligible for telehealth reimbursement under Medicare (fee-for-service) FFS through existing Center for Medicare and Medicaid Services (CMS) guidance as of January 2020, in addition to temporary coding guidance specific to COVID-19 effective as of March 1, 2020. Avalere’s analysis highlights the immediate potential for specific physician specialties to utilize telehealth based on temporary flexibilities regarding which procedures are eligible for telehealth reimbursement.